PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
Data
2020Número do documento
PAHO/IMS/PHE/COVID-19/20-0040
Metadata
Mostrar registro completoOutros idiomas
Resumo
PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects. The information included in this note reflects the available evidence at the date of publication.
Assunto
Collections
Este aviso deve ser preservado juntamente com o URL original do artigo.Attribution-NonCommercial-ShareAlike 3.0 IGO
Itens relacionados
Apresentado os itens relacionados pelo título, autor e assunto.
-
Delgado Zegarra, Jaime; da Silva Gomes, Fabio (2021)[RESUMEN]. Objetivo. Identificar el perfil nutricional de productos alimentarios eximidos de presentar uno o más sellos de advertencia nutricional en el frente del envase durante la primera etapa de vigencia de la Ley 30021 ...
-
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (PAHOUnited StatesWashington, D.C., 2021)The aim of this study was to map existing country policies and initiatives addressing population dietary sodium reduction in the Region of the Americas; to identify policy gaps following what is outlined in the World Health ...
-
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (PAHOUnited StatesWashington, D.C., 2021)This publication presents the set of new and revised Pan American Health Organization (PAHO) Regional Sodium Reduction Targets 2021–2025 adopted by the PAHO Technical Advisory Group on Cardiovascular Disease Prevention ...